Grant B, Sandelson M, Agyemang-Prempeh B, et al
A provider must submit a prescription and prior authorization request to a CMS central processor confirming eligibility
Because it targets multiple hormonal pathways involved in appetite, blood sugar regulation, and energy balance, many people are actively searching for information on how to get retatrutide, who may qualify, and what options currently exist
While Retatrutide has generated significant excitement in obesity medicine due to encouraging clinical trial results, it remains an investigational medication that is currently in Phase 3 clinical trials and has not yet received FDA approval
Food and Drug Administration (FDA) Consumer Updates on GLP-1 Receptor Agonist Safety Mandates, Approved Semaglutide Clinical Guidance, and Public Health Alerts (USA Gov)